HLA-A and colorectal carcinoma: Samples were obtained from two colorectal cancer patients CRC-1 (HLA-A*03:01; HLA-A*02:07) and CRC-2 (HLA-A*24:02; HLA-A*30:01), and individualized neoantigen-reactive T cell screening was performed (Supplementary Figure S4A).